Daily Oncology News Alerts

2014 COA Community Oncology Conference Coverage (4/23/2014) - Our friends at OBR Oncology have posted a full report of the 2014 COA Community Oncology Conference. In their coverage they have a number of videos including a discussion of What’s Impacting Cancer Care? with COA’s own Executive Director Ted Okon, a Community Oncology 2.0 Medical Home Report with Dr. Daniel McKeller, MD, and How to Innovate [...]
Office Visit: No Fix For Doc Fix (4/23/2014) - By: David Holden Why do Americans put up with mediocrity? Apathy? The answer could only be because Americans feel hopeless. The hopelessness stems from watching an ineffective Congress continue to shirk responsibility and make excuses. Republican U.S. Sen. Tom Coburn is tired and done with ineffectiveness and lack of accountability. He was furious over Congress’ recent [...]
Breast Cancer Drug Turned Down For NHS Use Due To High Cost (4/23/2014) - Decision on Herceptin-style drug which costs £90,000 but can prolong lives by nearly six months heavily criticized Case study: ‘Without it, I wouldn’t be here’ Sarah Boseley, health editor A Herceptin-style drug that can offer some women with advanced breast cancer nearly six months of extra life has been turned down for use in the NHS because of its [...]
FDA NEWS RELEASE (4/22/2014) - For Immediate Release: April 21, 2014 Media Inquiries: Stephanie Yao, 301-796-0394, stephanie.yao@fda.hhs.gov Consumer Inquiries: 888-INFO-FDA FDA approves Cyramza for stomach cancer The U.S. Food and Drug Administration today approved Cyramza (ramucirumab) to treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma, a form of cancer located in the region where the esophagus joins the stomach. Stomach cancer forms [...]
Study Examines Patient Care Patterns in Medicare Accountable Care Organizations (4/22/2014) - EMBARGOED FOR RELEASE: 3 P.M. (CT), MONDAY, APRIL 21, 2014 Media Advisory: To contact author J. Michael McWilliams, M.D., Ph.D., call David Cameron at 617-432-0441 or email David_Cameron@hms.harvard.edu. To contact commentary author Paul B. Ginsburg, Ph.D., call Sadena Thevarajah at 213-821-7978 or email thevaraj@healthpolicy.usc.edu. JAMA Internal Medicine Bottom Line:  A third of Medicare beneficiaries assigned to accountable [...]
Study: Community Demographics—Not Quality of Care—Drive Hospital Readmissions (4/22/2014) - by Rajiv Leventhal Rather than a hospital’s quality of care, its geographic location is the primary driving factor behind readmissions, according to a recent study in Health Services Research, part of the Center for Advancing Health. The study found that nearly 60 percent of the variation in hospital readmission rates appears to be associated with where the hospital [...]
Novartis to Buy Glaxo Cancer Drugs, Sell Animal Health (4/22/2014) - By Oliver Staley Novartis AG (NOVN) will focus more on cancer,GlaxoSmithKline Plc (GSK) on vaccines and Eli Lilly & Co. (LLY) on animal health as the drugmakers announced a series of deals for a total of as much as $28.5 billion today. The transactions, as well as a plan to form a consumer-health joint venture with Glaxo, are part [...]
New Jerseyans Find It Hard To Find Doctors Who Accept Their Insurance (4/18/2014) - By ANDREW KITCHENMAN Quest for physicians who take their health coverage proves much more difficult for NJ residents compared to national average New Jersey residents are more than four times as likely as the national average to have difficulty finding a doctor who accepts their health insurance, according to a new Rutgers University report. Of state residents [...]